双成药业
(002693)
| 流通市值：53.77亿 | | | 总市值：54.20亿 |
| 流通股本：4.11亿 | | | 总股本：4.15亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 37,070,882.11 | 18,094,704.09 | 17,684,279.51 | 3,387,155.56 |
| 应收票据及应收账款 | 12,093,332.93 | 26,892,148.36 | 14,324,889.52 | 14,753,224.78 |
| 其中：应收票据 | 624,533.5 | 1,134,533.5 | - | 916,580 |
| 应收账款 | 11,468,799.43 | 25,757,614.86 | 14,324,889.52 | 13,836,644.78 |
| 应收款项融资 | 1,156,326.76 | 639,308.01 | 359,856 | 1,605,884 |
| 预付款项 | 2,987,887.46 | 4,333,741.85 | 2,108,202.39 | 730,839.78 |
| 其他应收款合计 | 11,555,958.88 | 11,603,572.73 | 11,749,027.09 | 11,739,290.79 |
| 存货 | 81,110,139.23 | 70,984,512.57 | 76,737,810.69 | 74,306,716.84 |
| 其他流动资产 | 34,204.3 | 30,966.61 | 20,093.19 | 195,612.46 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 159,187,994.54 | 157,618,085.67 | 131,101,295.59 | 135,235,873.61 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 投资性房地产 | 13,942,370.01 | 16,572,920.01 | 16,690,848.03 | 16,376,129.6 |
| 固定资产 | 415,717,631.48 | 425,439,328.66 | 433,825,880.88 | 439,599,007.87 |
| 在建工程 | 20,578,988.8 | 18,104,476.74 | 16,019,649.75 | 17,997,751.73 |
| 无形资产 | 75,911,671.31 | 76,436,425.89 | 69,719,050.54 | 52,810,444.94 |
| 开发支出 | 112,263,375.97 | 103,397,725.17 | 105,561,156.71 | 118,971,093.95 |
| 长期待摊费用 | 6,127,848.49 | 6,432,138.19 | 6,818,384.87 | 5,244,510.94 |
| 递延所得税资产 | 995,920.27 | 1,003,955.4 | 1,516,620.18 | 1,516,620.18 |
| 其他非流动资产 | 9,834,736.06 | 4,835,669.48 | 7,203,946.03 | 5,496,689.07 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 665,372,542.39 | 662,222,639.54 | 667,355,536.99 | 668,012,248.28 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 824,560,536.93 | 819,840,725.21 | 798,456,832.58 | 803,248,121.89 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 19,370,017.2 | 14,862,437.09 | 15,830,517.78 | 17,136,336.58 |
| 应付账款 | 19,370,017.2 | 14,862,437.09 | 15,830,517.78 | 17,136,336.58 |
| 预收款项 | 1,090,105.87 | 2,326,308.81 | 815,849.12 | 1,487,616.1 |
| 合同负债 | 40,169,812.54 | 30,589,562.26 | 29,308,156.64 | 31,878,051.04 |
| 应付职工薪酬 | 7,061,771.96 | 7,143,747.44 | 7,192,502.72 | 9,901,443.04 |
| 应交税费 | 3,247,664.7 | 2,698,101.56 | 1,878,491.79 | 3,718,016.61 |
| 其他应付款合计 | 65,610,046.88 | 66,892,872.91 | 63,166,971.44 | 65,220,460.99 |
| 一年内到期的非流动负债 | 22,232,700 | 21,038,511.73 | 10,570,389.11 | 10,050,750 |
| 其他流动负债 | 1,080,886.73 | 494,234.78 | 479,670.39 | 549,403.79 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 159,863,005.88 | 146,045,776.58 | 129,242,548.99 | 139,942,078.15 |
| 非流动负债: | | | | |
| 长期借款 | 187,000,000 | 170,000,000 | 155,021,388.89 | 135,000,000 |
| 递延收益 | 9,071,465.8 | 7,723,359.84 | 7,875,253.88 | 8,027,147.92 |
| 递延所得税负债 | 2,347,219.08 | 2,416,753 | 2,633,298.09 | 2,633,298.09 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 198,418,684.88 | 180,140,112.84 | 165,529,940.86 | 145,660,446.01 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 358,281,690.76 | 326,185,889.42 | 294,772,489.85 | 285,602,524.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 414,689,750 | 416,789,750 | 416,789,750 | 416,728,930 |
| 资本公积 | 369,913,602.2 | 371,824,602.2 | 371,824,625.65 | 371,653,193.41 |
| 减:库存股 | - | 4,011,000 | 4,011,000 | 4,011,000 |
| 其他综合收益 | -351,727.6 | -354,343.21 | -354,035.41 | -351,181.7 |
| 盈余公积 | 34,425,232.98 | 34,425,232.98 | 34,425,232.98 | 34,425,232.98 |
| 未分配利润 | -384,796,971.33 | -363,905,446.13 | -355,701,958.88 | -346,959,282.11 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 433,879,886.25 | 454,768,795.84 | 462,972,614.34 | 471,485,892.58 |
| 少数股东权益 | 32,398,959.92 | 38,886,039.95 | 40,711,728.39 | 46,159,705.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 466,278,846.17 | 493,654,835.79 | 503,684,342.73 | 517,645,597.73 |
| 负债和股东权益合计 | 824,560,536.93 | 819,840,725.21 | 798,456,832.58 | 803,248,121.89 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |